Results 71 to 80 of about 58,709 (316)

Incidence of postoperative retinal detachment and bacterial endophthalmitis in the Swedish national paediatric cataract register and associated risk factors

Acta Ophthalmologica, EarlyView.
Abstract Purpose To investigate the incidence and risk factors of retinal detachment (RD) and bacterial endophthalmitis in a cohort of children who underwent cataract surgery before the age of eight. Methods Data was retrieved from the Swedish national paediatric cataract register.
Arzu Seyhan Karatepe Hashas, Anna Linnarsson Wiklund, Jenny Gyllén, Birgitte Haargaard, Gunilla Magnusson, Alf Nyström, Kristina Tornqvist, Eric Trocmé, Ulrika Kjellström   +8 more
wiley   +1 more source

Sucessfull management of bilateral presumed Candida endogenous endophtalmitis following pancreatitis

Revista Brasileira de Oftalmologia, 2016
Endogenous endophthalmitis is a rare, and frequently devastating, ophthalmic disease. It occurs mostly in immunocompromised patients, or those with diabetes mellitus, cancer or intravenous drugs users.
Ricardo Evangelista Marrocos de Aragão, Ieda Maria Alexandre Barreira, Francisco Holanda Oliveira Neto, Felipe de Freitas Beserra, Cesar Pereira de Araujo, Carine Soares Ramos do Nascimento   +5 more
doaj   +1 more source

Ocular sequelae from the illicit use of class A drugs [PDF]

, 2004
Aim: To highlight the changes that may take place in the visual system of the class A drug abuser. Methods: A literature review was carried out of ocular/visual sequelae of the more common class A drugs.
Firth, A.Y.
core  

Long‐term results after sutureless intrascleral fixation of the Carlevale intraocular lens: Changes in scleral pocket thickness over time

Acta Ophthalmologica, EarlyView.
Abstract Purpose To investigate the long‐term effects and dynamic changes in scleral thickness above the T‐haptic after sutureless scleral‐fixated intraocular lens (sSFIOL) implantation using the FIL‐SFF Carlevale lens. Setting Single‐centre, single‐surgeon, prospective clinical trial, Department of Ophthalmology, Medical University of Vienna, Austria.
Markus Schranz, Ioanna Dimakopoulou, Marcus Lisy, Victor Danzinger, Daniel Schartmüller, Claudette Abela‐Formanek   +5 more
wiley   +1 more source

Second‐Generation (44‐Channel) Suprachoroidal Retinal Prosthesis: Surgical Stability and Safety During a 2‐Year Clinical Trial

Clinical &Experimental Ophthalmology, EarlyView.
ABSTRACT Background To assess the safety and stability profile of the suprachoroidal retinal prosthesis (ScRP) in participants with retinitis pigmentosa (RP) for 2 years from implantation. Methods Four participants, with advanced RP and bare‐light perception vision were enrolled in a prospective, single arm unmasked interventional clinical trial and ...
Penelope J. Allen, Maria Kolic, Elizabeth K. Baglin, Samuel A. Titchener, Jessica Kvansakul, David A. X. Nayagam, Jonathan Yeoh, Robert J. Briggs, Joel Villalobos, Christopher E. Williams, Myra B. McGuinness, Chi D. Luu, Matthew A. Petoe, Carla J. Abbott, for the Bionics Institute and Centre for Eye Research Australia Retinal Prosthesis Consortium   +14 more
wiley   +1 more source

Role of Inflammation in Endophthalmitis [PDF]

Mediators of Inflammation, 2012
Inflammation originating from infection of the vitreous cavity is called endophthalmitis. Attention has been focused on the epidemiologic, microbiologic reports, and treatment options; unfortunately, the role of the host immune reaction in the visual function damage is still not well understood.
Vallejo Garcia J. L., Asencio Duran M., Pastora Salvador N., Vinciguerra P., ROMANO, MARIO   +4 more
openaire   +5 more sources

Safety of an Intravitreal Bevacizumab Biosimilar (MVASI)

Clinical &Experimental Ophthalmology, EarlyView.
ABSTRACT Background Intravitreal bevacizumab has been used off‐label to treat multiple ocular conditions for almost two decades. Reference bevacizumab, Avastin, was discontinued in Australia in 2021. A bevacizumab biosimilar, MVASI, was approved by the Therapeutic Goods Administration for the treatment of metastatic cancer in 2020.
Hanru Wang, Bobak Bahrami, Sonia Huang, Marzieh Tahmasebi Sarvestani, Sudha Cugati, Stewart Lake, Weng Onn Chan, Devaraj Supramaniam, Matthew Little   +8 more
wiley   +1 more source

Current Evidence for the Prevention of Endophthalmitis in Anti-VEGF Intravitreal Injections

Journal of Ophthalmology, 2018
Intravitreal injection of a therapeutic substance is the most common procedure performed in ophthalmology. It has a low incidence of serious complications but is associated with a small chance of endophthalmitis.
P. Lau, K. S. Jenkins, Christopher J. Layton   +2 more
semanticscholar   +1 more source

Preferred practice patterns of endophthalmitis management and prevention: A survey among the members of Vitreoretinal Society of India – Study by the VRSI study group

Indian Journal of Ophthalmology
Purpose: To assess the preferred practice patterns of endophthalmitis management and prophylaxis among the members of Vitreo Retina Society of India (VRSI).
Deepanshu Agrawal, Anil B Gangwe, Koushik Tripathy, Pradeep Sagar, P Mahesh Shanmugam, Manisha Agrawal, Deepshikha Agrawal, Raj Vardhan Azad   +7 more
doaj   +1 more source

Review of Clinical Features, Microbiological Spectrum, and Treatment Outcomes of Endogenous Endophthalmitis over an 8-Year Period

Journal of Ophthalmology, 2012
Purpose. To evaluate the clinical features, microbiological spectrum, and treatment outcomes of endogenous endophthalmitis. Methods. Retrospective review of consecutive cases with infective endogenous endophthalmitis presenting from 2000 to 2007.
Zenith H. Y. Wu, Rose P. S. Chan, Fiona O. J. Luk, David T. L. Liu, Carmen K. M. Chan, Dennis S. C. Lam, Timothy Y. Y. Lai   +6 more
doaj   +1 more source